Matching-adjusted indirect comparisons of oral rimegepant versus placebo,erenumab, and galcanezumab examining monthly migraine days and health-related quality of life in the treatment of migraine
1. Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada;2. Biohaven Pharmaceuticals, New Haven, CT, USA;3. The Headache Clinic, Island Hospital, Anacortes, WA, USA